{"schema_version":"1","generated_at":"2026-11-05T06:38:39.778Z","data_as_of":"2026-11-04","url":"https://www.findmykol.com/kol/joshua-berlin","json_url":"https://www.findmykol.com/kol/joshua-berlin/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"joshua-berlin","name":"Joshua Berlin","credential":"MD","title":"Owner, Joshua M. Berlin MD Dermatology","specialty":"Dermatology","specialty_raw":"Dermatology","therapeutic_area":"Dermatology","therapeutic_areas":["Dermatology"],"institution":"Premier Dermatology Partners","institution_url":"https://www.findmykol.com/institution/premier-dermatology-partners","city":"Boynton Beach","state":"FL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1548241573","openalex":"A5019165813"},"summary":"Joshua Berlin is Owner, Joshua M. Berlin MD Dermatology at Premier Dermatology Partners. OpenAlex indexes 28 publications with 450 citations (h-index 10); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.","overview":{"text":"Joshua Berlin, MD, is Owner, Joshua M. Berlin MD Dermatology at Premier Dermatology Partners. The public record shows 28 publications with 450 citations (h-index 10), centered on Acne / Hidradenitis, Acne Vulgaris. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 23 companies.","bullets":["Top research focus: Acne / Hidradenitis","3 registered trials on ClinicalTrials.gov","Open Payments reporting from 23 companies"],"generated_at":"2026-11-04"},"focus":{"indications":[{"label":"Acne / Hidradenitis","therapeutic_area":"Dermatology","trials":2,"topics":0,"strength":6},{"label":"Acne Vulgaris","therapeutic_area":"Dermatology","trials":2,"topics":0,"strength":6},{"label":"Purpura","therapeutic_area":"Hematology","trials":1,"topics":0,"strength":3},{"label":"Atopic Dermatitis / Eczema","therapeutic_area":"Dermatology","trials":0,"topics":0,"strength":1},{"label":"Psoriasis (Derm)","therapeutic_area":"Dermatology","trials":0,"topics":0,"strength":1},{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Asthma","therapeutic_area":"Respiratory","trials":0,"topics":0,"strength":1},{"label":"Psoriasis / Psoriatic Arthritis","therapeutic_area":"Rheumatology/Immunology","trials":0,"topics":0,"strength":1},{"label":"Gastroesophageal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Lupus (SLE)","therapeutic_area":"Rheumatology/Immunology","trials":0,"topics":0,"strength":1}],"research_topics":["Acne / Hidradenitis","Acne Vulgaris"],"drugs_studied":{"total":12,"shown":3,"withheld":9,"rows":[{"name":"Vtama","generic":"Tapinarof","trials":0,"payments":27,"publications":0,"mentions":27},{"name":"Skyrizi","generic":"Risankizumab","trials":0,"payments":15,"publications":0,"mentions":15},{"name":"Zoryve","generic":"Roflumilast","trials":0,"payments":10,"publications":0,"mentions":10}]},"works_with":{"total":24,"shown":3,"withheld":21,"rows":[{"name":"Dermavant Sciences, Inc.","trials":0,"payments":24,"mentions":24},{"name":"Abbvie Inc.","trials":0,"payments":22,"mentions":22},{"name":"Arcutis Biotherapeutics, Inc.","trials":0,"payments":10,"mentions":10}]}},"scholarship":{"works_count":28,"cited_by_count":450,"h_index":10,"latest_activity_year":2025,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT01951417","title":"Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris","phase":"PHASE4","status":"COMPLETED","role":"Investigator","sponsor":"Galderma R&D","source_url":"https://clinicaltrials.gov/study/NCT01951417","trial_url":"https://www.findmykol.com/trial/NCT01951417"},{"nct":"NCT01301586","title":"A Novel Combination Oral Agent to Treat Acne Vulgaris","phase":"PHASE1/PHASE2","status":"UNKNOWN","role":"Investigator","sponsor":"Nexgen Dermatologics, Inc.","source_url":"https://clinicaltrials.gov/study/NCT01301586","trial_url":"https://www.findmykol.com/trial/NCT01301586"},{"nct":"NCT01183910","title":"A Novel Oral Natural Extract for the Treatment of Senile Purpura","phase":"NA","status":"UNKNOWN","role":"Investigator","sponsor":"Nexgen Dermatologics, Inc.","source_url":"https://clinicaltrials.gov/study/NCT01183910","trial_url":"https://www.findmykol.com/trial/NCT01183910"}],"source":"trials"},"payments":{"company_count":23,"program_years":{"first":2021,"last":2025},"rows_total":37,"shown":3,"withheld":34,"rows":[{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":134.75,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1548241573"},{"payer":"Arcutis Biotherapeutics, Inc.","program_year":2025,"amount_usd":79.33,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1548241573"},{"payer":"Organon LLC","program_year":2025,"amount_usd":51.93,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1548241573"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1548241573","source":"payments"},"prescribing":{"data_year":2024,"areas_total":9,"areas_shown":3,"areas":[{"area":"Anti-infectives","share_pct":29.9,"classes_total":7,"classes":[{"class":"Azole Antifungal","setting":"prescribed","share_pct":15.9,"drugs":[{"name":"Ketoconazole","share_pct":100}],"max_beneficiaries":260},{"class":"Tetracycline-class Drug","setting":"prescribed","share_pct":3.9,"drugs":[{"name":"Doxycycline Hyclate","share_pct":100}],"max_beneficiaries":92}]},{"area":"Respiratory","share_pct":25.9,"classes_total":2,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":14.2,"drugs":[{"name":"Mometasone Furoate","share_pct":100}],"max_beneficiaries":252},{"class":"RNA Synthetase Inhibitor Antibacterial","setting":"prescribed","share_pct":11.6,"drugs":[{"name":"Mupirocin","share_pct":100}],"max_beneficiaries":243}]},{"area":"Sensory organs","share_pct":24,"classes_total":2,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":22.1,"drugs":[{"name":"Hydrocortisone","share_pct":52.9},{"name":"Clobetasol Propionate","share_pct":35.3},{"name":"Betamethasone Dipropionate","share_pct":6.1},{"name":"Desonide","share_pct":5.6}],"max_beneficiaries":228},{"class":"Aminoglycoside Antibacterial","setting":"prescribed","share_pct":1.9,"drugs":[{"name":"Gentamicin Sulfate","share_pct":100}],"max_beneficiaries":47}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":0,"rows_total":23,"shown":3,"withheld":20,"rows":[{"project":"R21NS095158","title":"Novel cellular approach to study acute neuronal hyperexcitability in a traumatic brain injury model","fiscal_year":2017,"amount_usd":195450,"organization":"RBHS-NEW JERSEY MEDICAL SCHOOL","source_url":"https://reporter.nih.gov/quickSearch/R21NS095158"},{"project":"R21NS095158","title":"Novel cellular approach to study acute neuronal hyperexcitability in a traumatic brain injury model","fiscal_year":2016,"amount_usd":240500,"organization":"RBHS-NEW JERSEY MEDICAL SCHOOL","source_url":"https://reporter.nih.gov/quickSearch/R21NS095158"},{"project":"R01GM057253","title":"Molecular Mechanism of Ion Transport by the Na, K-pump","fiscal_year":2006,"amount_usd":327987,"organization":"UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL","source_url":"https://reporter.nih.gov/quickSearch/R01GM057253"}],"source":"grants"},"publications":{"total":28,"shown":5,"withheld":23,"matched_by":"OpenAlex author record","recent":[{"title":"Dermatology Emergencies","year":2018,"journal":"Journal of the Dermatology Nurses’ Association","source_url":"https://doi.org/10.1097/jdn.0000000000000394","status":"verified"},{"title":"Dermatology Emergencies","year":2016,"journal":"Journal of the Dermatology Nurses’ Association","source_url":"https://doi.org/10.1097/jdn.0000000000000222","status":"verified"},{"title":"Critical Considerations on Optimizing Topical Corticosteroid Therapy","year":2015,"journal":"PubMed Central","status":"verified"},{"title":"[Not Available].","year":2015,"journal":"PubMed","status":"verified"},{"title":"Multicenter Prospective Cohort Study of the Incidence of Adverse Events Associated With Cosmetic Dermatologic Procedures","year":2014,"journal":"JAMA Dermatology","source_url":"https://doi.org/10.1001/jamadermatol.2014.2494","status":"verified"}],"most_cited":{"total":28,"shown":5,"withheld":23,"rows":[{"title":"Multicenter Prospective Cohort Study of the Incidence of Adverse Events Associated With Cosmetic Dermatologic Procedures","year":2014,"cited_by_count":62,"type":"article","source_url":"https://doi.org/10.1001/jamadermatol.2014.2494"},{"title":"Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery.","year":2008,"cited_by_count":60,"type":"article","source_url":"https://openalex.org/A5019165813"},{"title":"The significance of tumor persistence after incomplete excision of basal cell carcinoma","year":2002,"cited_by_count":59,"type":"article","source_url":"https://doi.org/10.1067/mjd.2002.117733"},{"title":"Metastatic Basal Cell Carcinoma Presenting as Unilateral Axillary Lymphadenopathy: Report of a Case and Review of the Literature","year":2002,"cited_by_count":53,"type":"article","source_url":"https://doi.org/10.1046/j.1524-4725.2002.02090.x"},{"title":"Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis","year":2000,"cited_by_count":46,"type":"article","source_url":"https://doi.org/10.1016/s1081-1206(10)62434-9"}]},"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/joshua-berlin-md","status":"verified"}]},"mentions":{"total":6,"shown":3,"rows":[{"url":"https://www.facebook.com/p/Premier-Dermatology-Partners-Joshua-Berlin-MD-100089606782613/","platform":"facebook","status":"verified"},{"url":"https://berlindermatology.com/providers/joshua-m-berlin-md/","platform":"other","status":"provisional"},{"url":"https://www.healthgrades.com/physician/dr-joshua-berlin-xcnl7","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"Graduated from Penn State University College of Medicine in 1999","source_url":"https://www.healthgrades.com/physician/dr-joshua-berlin-xcnl7","status":"provisional","collected_at":"2026-11-04"},{"value":"MD","source_url":"https://www.topdermatology.com/joshua-berlin-md/","status":"provisional","collected_at":"2026-11-04"}]}},"similar":[{"name":"Robert Modlin","slug":"robert-modlin","institution":"University of California, Los Angeles","specialty":"Dermatology","url":"https://www.findmykol.com/kol/robert-modlin","json_url":"https://www.findmykol.com/kol/robert-modlin/profile.json"},{"name":"Jon Hanifin","slug":"jon-hanifin","institution":"Oregon Health & Science University (OHSU)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/jon-hanifin","json_url":"https://www.findmykol.com/kol/jon-hanifin/profile.json"},{"name":"Heidi Kong","slug":"heidi-kong","institution":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/heidi-kong","json_url":"https://www.findmykol.com/kol/heidi-kong/profile.json"},{"name":"Joel Gelfand","slug":"joel-gelfand","institution":"University of Pennsylvania","specialty":"Dermatology","url":"https://www.findmykol.com/kol/joel-gelfand","json_url":"https://www.findmykol.com/kol/joel-gelfand/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":34,"funding":20,"publications":23}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-04"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-04"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-11-04"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}